Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Current Oncology (Toronto, Ont.)|November 26, 2025
Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case ReportCamilla Lisanti, Serena Della Rossa, Emma Zottarelli, et al.
BMC Cancer|October 13, 2009
Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancersGianMaria Miolo, Vincenzo Canzonieri, Clelia De Giacomi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2012
Locoregional failure in early-stage breast cancer patients treated with radical mastectomy and adjuvant systemic therapy: which patients benefit from postmastectomy irradiation?Marco Trovo, Elena Durofil, Jerry Polesel, et al.
The American Journal of Pathology|February 13, 2002
Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cellsDonatella Aldinucci, Dalisa Poletto, Annunziata Gloghini, et al.
Frontiers in Immunology|January 31, 2022
KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast CancerElena Muraro, Mariangela De Zorzi, Gianmaria Miolo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 31, 2022
Drip-and-ship toward mothership model for mechanical thrombectomy during COVID-19 pandemic: a retrospective analysisMatteo Paolucci, Sara Biguzzi, Francesco Cordici, et al.
Human Pathology|May 12, 2009
Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literatureDebora Lorenzon, Tiziana Perin, Pietro Bulian, et al.
The Journal of Molecular Diagnostics : JMD|October 4, 2008
Delineation of HER2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologistsAntonino Carbone, Gerardo Botti, Annunziata Gloghini, et al.
Annals of Surgical Oncology|June 22, 2011
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategiesClaudio Belluco, Antonino De Paoli, Vincenzo Canzonieri, et al.
Tumori|June 25, 2010
Epirubicin and docetaxel as neoadjuvant treatment of locally advanced breast cancer: a phase II studyDavide Lombardi, Simona Scalone, Diana Crivellari, et al.
Pageof 7